Company intelligence / Profile preview
Suzhou Suncadia Biopharmaceutical
Suzhou, Jiangsu, China
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Other
01
Overview
Suzhou Suncadia Biopharmaceutical is a prominent Chinese biotechnology company and a core subsidiary of Jiangsu Hengrui Pharmaceuticals. The company focuses on the research, development, and large-scale manufacturing of innovative biologics, particularly in the fields of oncology and autoimmune diseases. Its flagship product, camrelizumab (AiRuiKa), is a PD-1 inhibitor that has received multiple approvals in China for various cancer indications. Suncadia operates advanced R&D facilities and large-scale GMP-compliant manufacturing bases in Suzhou, supporting a robust pipeline of next-generation antibodies and antibody-drug conjugates.
- Therapeutic areas
- OncologyDermatology
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodyAntibody-drug conjugateBiologic
- Industry
- Pharma
02
Drug pipeline
23 assets22 more assets in the full pipeline.
Request access →03
Partnerships
Elevar TherapeuticsIncyte
Beyond the preview
Go deeper on Suzhou Suncadia Biopharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Suzhou Suncadia Biopharmaceutical.